51
|
Padilla-Cabello J, Santisteban-Espejo A, Heradio R, Cobo MJ, Martin-Piedra MA, Moral-Munoz JA. Methods for identifying biomedical translation: a systematic review. Am J Transl Res 2022; 14:2697-2708. [PMID: 35559386 PMCID: PMC9091120] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2021] [Accepted: 12/30/2021] [Indexed: 06/15/2023]
Abstract
Translational medicine is an important area of biomedicine, and has significantly facilitated the development of biomedical research. Despite its relevance, there is no consensus on how to evaluate its progress and impact. A systematic review was carried out to identify all the methods to evaluate translational research. Seven methods were found according to the established criteria to analyze their characteristics, advantages, and limitations. They allow us to perform this type of evaluation in different ways. No relevant advantages were found between them; each one presented its specific limitations that need to be considered. Nevertheless, the Triangle of Biomedicine could be considered the most relevant method, concerning the time since its publication and usefulness. In conclusion, there is still a lack of a gold-standard method for evaluating biomedical translational research.
Collapse
Affiliation(s)
- Javier Padilla-Cabello
- Program of Biomedicine, University of GranadaGranada, Spain
- Department of Otorhinolaryngology, Hospital Universitario Clínico San CecilioGranada, Spain
| | - Antonio Santisteban-Espejo
- Department of Pathology, Puerta del Mar University HospitalCadiz, Spain
- Institute of Research and Innovation in Biomedical Sciences of The Province of Cadiz (INiBICA)Cadiz, Spain
| | - Ruben Heradio
- School of Computer Science, Universidad Nacional de Educación a Distancia (UNED)Madrid, Spain
| | - Manuel J Cobo
- Department of Computer Science and Engineering, University of CadizPuerto Real, Spain
| | | | - Jose A Moral-Munoz
- Institute of Research and Innovation in Biomedical Sciences of The Province of Cadiz (INiBICA)Cadiz, Spain
- Department of Nursing and Physiotherapy, University of CadizCadiz, Spain
| |
Collapse
|
52
|
Kwan BM, Brownson RC, Glasgow RE, Morrato EH, Luke DA. Designing for Dissemination and Sustainability to Promote Equitable Impacts on Health. Annu Rev Public Health 2022; 43:331-353. [PMID: 34982585 PMCID: PMC9260852 DOI: 10.1146/annurev-publhealth-052220-112457] [Citation(s) in RCA: 81] [Impact Index Per Article: 27.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Designing for dissemination and sustainability (D4DS) refers to principles and methods for enhancing the fit between a health program, policy, or practice and the context in which it is intended to be adopted. In this article we first summarize the historical context of D4DS and justify the need to shift traditional health research and dissemination practices. We present a diverse literature according to a D4DS organizing schema and describe a variety of dissemination products, design processes and outcomes, and approaches to messaging, packaging, and distribution. D4DS design processes include stakeholder engagement, participatory codesign, and context and situation analysis, and leverage methods and frameworks from dissemination and implementation science, marketing and business, communications and visualarts, and systems science. Finally, we present eight recommendations to adopt a D4DS paradigm, reflecting shifts in ways of thinking, skills and approaches, and infrastructure and systems for training and evaluation.
Collapse
Affiliation(s)
- Bethany M Kwan
- Department of Family Medicine and Adult & Child Consortium for Health Outcomes Research and Delivery Science, University of Colorado School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA;
| | - Ross C Brownson
- Prevention Research Center, Brown School, Washington University in St. Louis, St. Louis, Missouri, USA
- Department of Surgery (Division of Public Health Sciences) and Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri, USA
| | - Russell E Glasgow
- Department of Family Medicine and Adult & Child Consortium for Health Outcomes Research and Delivery Science, University of Colorado School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA;
| | - Elaine H Morrato
- Parkinson School of Health Sciences and Public Health and Institute for Translational Medicine, Loyola University Chicago, Maywood, Illinois, USA
| | - Douglas A Luke
- Center for Public Health Systems Science, Brown School, Washington University in St. Louis, St. Louis, Missouri, USA
| |
Collapse
|
53
|
Cross walk between consensus recommendations and new NCATS PAR-21-293 requirements for D&I in CTSA Hubs. J Clin Transl Sci 2022; 6:e17. [PMID: 35291219 PMCID: PMC8889223 DOI: 10.1017/cts.2022.4] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2021] [Revised: 12/23/2021] [Accepted: 01/10/2022] [Indexed: 11/15/2022] Open
|
54
|
Applying the lessons of implementation science to maximize feasibility and usability in team science intervention development. J Clin Transl Sci 2021; 5:e197. [PMID: 34888066 PMCID: PMC8634288 DOI: 10.1017/cts.2021.826] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2021] [Revised: 06/23/2021] [Accepted: 07/13/2021] [Indexed: 12/30/2022] Open
Abstract
The Science of Team Science (SciTS) has generated a substantial body of work detailing characteristics of effective teams. However, that knowledge has not been widely translated into accessible, active, actionable, evidence-based interventions to help translational teams enhance their team functioning and outcomes. Over the past decade, the field of Implementation Science has rapidly developed methods and approaches to increase the translation of biomedical research findings into clinical care, providing a roadmap for mitigating the challenges of developing interventions while maximizing feasibility and utility. Here, we propose an approach to intervention development using constructs from two Implementation Science frameworks, Consolidated Framework for Implementation Research, and Reach, Effectiveness, Adoption, Implementation, and Maintenance, to extend the Wisconsin Interventions for Team Science framework described in Rolland et al. 2021. These Implementation Science constructs can help SciTS researchers design, build, test, and disseminate interventions that meet the needs of both adopters, the institutional leadership that decides whether to adopt an intervention, and implementers, those actually using the intervention. Systematically considering the impact of design decisions on feasibility and usability may lead to the design of interventions that can quickly move from prototype to pilot test to pragmatic trials to assess their impact.
Collapse
|
55
|
An integrative review and practical guide to team development interventions for translational science teams: One size does not fit all. J Clin Transl Sci 2021; 5:e198. [PMID: 34888067 PMCID: PMC8634301 DOI: 10.1017/cts.2021.832] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2021] [Revised: 06/01/2021] [Accepted: 07/26/2021] [Indexed: 12/26/2022] Open
Abstract
As the need to tackle complex clinical and societal problems rises, researchers are increasingly taking on a translational approach. This approach, which seeks to integrate theories, methodologies, and frameworks from various disciplines across a team of researchers, places emphasis on translation of findings in order to offer practical solutions to real-world problems. While translational research leads to a number of positive outcomes, there are also a multitude of barriers to conducting effective team science, such as effective coordination and communication across the organizational, disciplinary, and even geographic boundaries of science teams. Given these barriers to success, there is a significant need to establish team interventions that increase science team effectiveness as translational research becomes the new face of science. This review is intended to provide translational scientists with an understanding of barriers to effective team science and equip them with the necessary tools to overcome such barriers. We provide an overview of translational science teams, discuss barriers to science team effectiveness, demonstrate the lacking state of current interventions, and present recommendations for improving interventions in science teams by applying best practices from the teams and groups literature across the four phases of transdisciplinary research.
Collapse
|
56
|
Rolland B, Hohl SD, Johnson LJ. Enhancing translational team effectiveness: The Wisconsin Interventions in Team Science framework for translating empirically informed strategies into evidence-based interventions. J Clin Transl Sci 2021; 5:e158. [PMID: 34527297 PMCID: PMC8427550 DOI: 10.1017/cts.2021.825] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2021] [Revised: 06/23/2021] [Accepted: 07/13/2021] [Indexed: 12/18/2022] Open
Abstract
Achieving the clinical, public health, economic, and policy benefits of translational science requires the integration and application of findings across biomedical, clinical, and behavioral science and health policy, and thus, collaboration across experts in these areas. To do so, translational teams need the skills, knowledge, and attitudes to mitigate challenges and build on strengths of cross-disciplinary collaboration. Though these competencies are not innate to teams, they can be built through the implementation of effective strategies and interventions. The Science of Team Science (SciTS) has contributed robust theories and evidence of empirically-informed strategies and best practices to enhance collaboration. Yet the field lacks methodological approaches to rigorously translate those strategies into evidence-based interventions to improve collaborative translational research. Here, we apply lessons from Implementation Science and Human-Centered Design & Engineering to describe the Wisconsin Interventions in Team Science (WITS) framework, a process for translating established team science strategies into evidence-based interventions to bolster translational team effectiveness. To illustrate our use of WITS, we describe how University of Wisconsin's Institute for Clinical and Translational Research translated the existing Collaboration Planning framework into a robust, scalable, replicable intervention. We conclude with recommendations for future SciTS research to refine and test the framework.
Collapse
Affiliation(s)
- Betsy Rolland
- Institute for Clinical and Translational Research, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA
- Carbone Cancer Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA
| | - Sarah D. Hohl
- Carbone Cancer Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA
| | - LaKaija J. Johnson
- Institute for Clinical and Translational Research, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA
| |
Collapse
|
57
|
Mehta TG, Mahoney J, Leppin AL, Stevens KR, Yousefi-Nooraie R, Pollock BH, Shelton RC, Dolor R, Pincus H, Patel S, Moore JB. Integrating dissemination and implementation sciences within Clinical and Translational Science Award programs to advance translational research: Recommendations to national and local leaders. J Clin Transl Sci 2021; 5:e151. [PMID: 34527291 PMCID: PMC8411263 DOI: 10.1017/cts.2021.815] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2021] [Revised: 07/01/2021] [Accepted: 07/02/2021] [Indexed: 12/16/2022] Open
Abstract
The National Center for Advancing Translational Sciences (NCATS) has defined translation as the process of turning observations into interventions that are adopted, sustained, and improve health. Translation must attend to research and community systems and context at multiple levels, and to key stakeholders. Dissemination and implementation (D&I) sciences are informed by an understanding of the critical role of people and systems in disseminating, adopting, and sustaining innovations within real-world settings. Thus, the D&I sciences provides a set of principles that can guide the translational work of Clinical and Translational Science Award (CTSA) programs from basic research to public health. In this special communication, our cross-domain working group of the CTSA consortium, comprised of experts in methods and processes, workforce development, evaluation, stakeholder engagement, and D&I sciences, share a vision of how CTSAs can enhance translation across the translational spectrum through the integration of D&I sciences into the critical areas of methods and processes, workforce development, and evaluation. We propose a set of recommendations for NCATS national and local leaders that are intended to move D&I sciences out of a position of unfamiliarity and ancillary value and into the core identity of who CTSAs are, how they think, and what they do, to advance translation and health.
Collapse
Affiliation(s)
- Tara G. Mehta
- Center for Clinical Translational Science, University of Illinois at Chicago, Chicago, IL, USA
| | - Jane Mahoney
- The Institute for Clinical and Translational Research, University of Wisconsin, Madison, WI, USA
| | - Aaron L. Leppin
- Center for Clinical and Translational Science, Mayo Clinic, Rochester, MN, USA
| | - Kathleen R. Stevens
- National Center for Advancing Translational Sciences, University of Texas Health Science Center, San Antonio, TX, USA
| | - Reza Yousefi-Nooraie
- Clinical and Translational Science Institute, University of Rochester, Rochester, NY, USA
| | - Brad H. Pollock
- Clinical and Translational Science Center, University of California, Davis, CA, USA
| | - Rachel C. Shelton
- Irving Institute for Clinical and Translational Research, Columbia University, New York, NY, USA
- Mailman School of Public Health, Department of Sociomedical Sciences, Columbia University, New York, NY, USA
| | - Rowena Dolor
- Duke Clinical and Translational Science Institute, Duke University School of Medicine, Durham, NC, USA
| | - Harold Pincus
- Irving Institute for Clinical and Translational Research, Columbia University, New York, NY, USA
- New York State Psychiatric Institute and Department of Psychiatry, Columbia University, New York, NY, USA
| | - Sapana Patel
- Irving Institute for Clinical and Translational Research, Columbia University, New York, NY, USA
- New York State Psychiatric Institute and Department of Psychiatry, Columbia University, New York, NY, USA
| | - Justin B. Moore
- Clinican and Translational Science Institute & Department of Implementation Science, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA
| |
Collapse
|
58
|
Conceptual models for implementing solution-oriented team science in large research consortia. J Clin Transl Sci 2021; 5:e139. [PMID: 34367683 PMCID: PMC8327547 DOI: 10.1017/cts.2021.802] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2021] [Revised: 05/28/2021] [Accepted: 06/06/2021] [Indexed: 11/26/2022] Open
Abstract
Large translational research initiatives can strengthen efficiencies and support science with enhanced impact when practical conceptual models guide their design, implementation, and evaluation. The National Institutes of Health (NIH) Environmental influences on Child Health Outcomes (ECHO) program brings together data from 72 ongoing maternal–child cohort studies – involving more than 50,000 children and over 1200 investigators – to conduct transdisciplinary solution-oriented research that addresses how early environmental exposures influence child health. ECHO uses a multi-team system approach to consortium-wide data collection and analysis to generate original research that informs programs, policies, and practices to enhance children’s health. Here, we share two conceptual models informed by ECHO’s experiences and the Science of Team Science. The first conceptual model illuminates a system of teams and associated tasks that support collaboration toward shared scientific goals. The second conceptual model provides a framework for designing evaluations for continuous quality improvement of manuscript writing teams. Together, the two conceptual models offer guidance for the design, implementation, and evaluation of translational and transdisciplinary multi-team research initiatives.
Collapse
|
59
|
Forsch N, Govil S, Perry JC, Hegde S, Young AA, Omens JH, McCulloch AD. Computational analysis of cardiac structure and function in congenital heart disease: Translating discoveries to clinical strategies. JOURNAL OF COMPUTATIONAL SCIENCE 2021; 52:101211. [PMID: 34691293 PMCID: PMC8528218 DOI: 10.1016/j.jocs.2020.101211] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
Increased availability and access to medical image data has enabled more quantitative approaches to clinical diagnosis, prognosis, and treatment planning for congenital heart disease. Here we present an overview of long-term clinical management of tetralogy of Fallot (TOF) and its intersection with novel computational and data science approaches to discovering biomarkers of functional and prognostic importance. Efforts in translational medicine that seek to address the clinical challenges associated with cardiovascular diseases using personalized and precision-based approaches are then discussed. The considerations and challenges of translational cardiovascular medicine are reviewed, and examples of digital platforms with collaborative, cloud-based, and scalable design are provided.
Collapse
Affiliation(s)
- Nickolas Forsch
- Department of Bioengineering, University of California San Diego, La Jolla, CA, USA
| | - Sachin Govil
- Department of Bioengineering, University of California San Diego, La Jolla, CA, USA
| | - James C Perry
- Department of Bioengineering, University of California San Diego, La Jolla, CA, USA
- Department of Pediatrics, University of California San Diego, La Jolla, CA, USA
| | - Sanjeet Hegde
- Department of Pediatrics, University of California San Diego, La Jolla, CA, USA
| | - Alistair A Young
- Department of Biomedical Engineering, King’s College London, London, UK
- Department of Anatomy and Medical Imaging, University of Auckland, Auckland, NZ
| | - Jeffrey H Omens
- Department of Bioengineering, University of California San Diego, La Jolla, CA, USA
- Deparment of Medicine, University of California San Diego, La Jolla, CA, USA
| | - Andrew D McCulloch
- Department of Bioengineering, University of California San Diego, La Jolla, CA, USA
- Deparment of Medicine, University of California San Diego, La Jolla, CA, USA
| |
Collapse
|
60
|
If you build it, will they come? Linking researcher engagement and scientific productivity in large infrastructure grants. J Clin Transl Sci 2021. [DOI: 10.1017/cts.2021.17] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
Abstract
Abstract
Introduction:
The NIH Clinical and Translational Science Awards (CTSA) Program supports the creation of program infrastructure promoting scientific collaboration and improvement in translational research. While most evaluations of these and similar programs focus on scientific outcomes such as grants and publications, few studies investigate the underlying mechanisms through which large infrastructure grants produce scientific or translational benefits. This study investigated how engagement – researchers’ interactions with CTSA-funded resources – can help to increase scientific productivity.
Methods:
Authors 1) developed process indicators to define engagement in the CTSA infrastructure at Washington University in St. Louis in four general categories (core service use, internal funding, mentor-mentee opportunities, and leadership roles); 2) explored the relationship between CTSA engagement and scholarly productivity; and 3) compared the relationships between engagement and productivity across gender and race/ethnicity. Mixed effects Poisson regressions modeled productivity outcomes on engagement, controlling for demographic and academic characteristics.
Results:
CTSA members who were engaged were more likely to publish papers and submit grants when compared to others. They were more likely to receive external grant awards – 10% to 20% percent more – than those who were not engaged. Productivity disparities between men and women and to a lesser extent across categories of race and ethnicity persisted even in samples matched on previous productivity levels.
Conclusions:
CTSAs could see larger growth in scientific productivity by increasing researcher engagement and addressing demographic disparities – possibly through focused communications to raise awareness of opportunities – and dissemination of case studies and success stories of engagement to membership.
Collapse
|
61
|
Participatory needs assessment and action planning for a clinical and translational research network. J Clin Transl Sci 2020; 5:e69. [PMID: 33948288 PMCID: PMC8057451 DOI: 10.1017/cts.2020.568] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
The goal of this study was to assess the utility of participatory needs assessment processes for continuous improvement of developing clinical and translational research (CTR) networks. Our approach expanded on evaluation strategies for CTR networks, centers, and institutes, which often survey stakeholders to identify infrastructure or resource needs, using the case example of the Great Plains IDeA-CTR Network. Our 4-stage approach (i.e., pre-assessment, data collection, implementation of needs assessment derived actions, monitoring of action plan) included a member survey (n = 357) and five subsequent small group sessions (n = 75 participants) to better characterize needs identified in the survey and to provide actionable recommendations. This participatory, mixed-methods needs assessment and strategic action planning process yielded 11 inter-related recommendations. These recommendations were presented to the CTR steering committee as inputs to develop detailed, prioritized action plans. Preliminary evaluation shows progress towards improved program capacity and effectiveness of the network to respond to member needs. The participatory, mixed-methods needs assessment and strategic planning process allowed a wide range of stakeholders to contribute to the development of actionable recommendations for network improvement, in line with the principles of team science.
Collapse
|
62
|
Rudd BN, Davis M, Beidas RS. Integrating implementation science in clinical research to maximize public health impact: a call for the reporting and alignment of implementation strategy use with implementation outcomes in clinical research. Implement Sci 2020; 15:103. [PMID: 33239097 PMCID: PMC7690013 DOI: 10.1186/s13012-020-01060-5] [Citation(s) in RCA: 82] [Impact Index Per Article: 16.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2020] [Accepted: 10/25/2020] [Indexed: 01/06/2023] Open
Abstract
BACKGROUND Although comprehensive reporting guidelines for implementation strategy use within implementation research exist, they are rarely used by clinical (i.e., efficacy and effectiveness) researchers. In this debate, we argue that the lack of comprehensive reporting of implementation strategy use and alignment of those strategies with implementation outcomes within clinical research is a missed opportunity to efficiently narrow research-to-practice gaps. MAIN BODY We review ways that comprehensively specifying implementation strategy use can advance science, including enhancing replicability of clinical trials and reducing the time from clinical research to public health impact. We then propose that revisions to frequently used reporting guidelines in clinical research (e.g., CONSORT, TIDieR) are needed, review current methods for reporting implementation strategy use (e.g., utilizing StaRI), provide pragmatic suggestions on how to both prospectively and retrospectively specify implementation strategy use and align these strategies with implementation outcomes within clinical research, and offer a case study of using these methods. CONCLUSIONS The approaches recommended in this article will not only contribute to shared knowledge and language among clinical and implementation researchers but also facilitate the replication of efficacy and effectiveness research. Ultimately, we hope to accelerate translation from clinical to implementation research in order to expedite improvements in public health.
Collapse
Affiliation(s)
- Brittany N Rudd
- Institute for Juvenile Research, Department of Psychiatry, University of Illinois at Chicago, 1747 West Roosevelt Road, Chicago, IL, 60608, USA.
- Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
- Penn Implementation Science Center, Leonard Davis Institute (PISCE@LDI), Philadelphia, PA, USA.
| | - Molly Davis
- Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
- Penn Implementation Science Center, Leonard Davis Institute (PISCE@LDI), Philadelphia, PA, USA
| | - Rinad S Beidas
- Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
- Penn Implementation Science Center, Leonard Davis Institute (PISCE@LDI), Philadelphia, PA, USA
- Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
- Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| |
Collapse
|
63
|
Dodson SE, Kukic I, Scholl L, Pelfrey CM, Trochim WM. A protocol for retrospective translational science case studies of health interventions. J Clin Transl Sci 2020; 5:e22. [PMID: 33948245 PMCID: PMC8057422 DOI: 10.1017/cts.2020.514] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2020] [Revised: 07/07/2020] [Accepted: 07/13/2020] [Indexed: 11/07/2022] Open
Abstract
The critical processes driving successful research translation remain understudied. We describe a mixed-method case study protocol for analyzing translational research that has led to the successful development and implementation of innovative health interventions. An overarching goal of these case studies is to describe systematically the chain of events between basic, fundamental scientific discoveries and the adoption of evidence-based health applications, including description of varied, long-term impacts. The case study approach isolates many of the key factors that enable the successful translation of research into practice and provides compelling evidence connecting the intervention to measurable changes in health and medical practice, public health outcomes, and other broader societal impacts. The goal of disseminating this protocol is to systematize a rigorous approach, which can enhance reproducibility, promote the development of a large collection of comparable studies, and enable cross-case analyses. This approach, an application of the "science of translational science," will lead to a better understanding of key research process markers, timelines, and potential points of leverage for intervention that may help facilitate decisions, processes, and policies to speed the sustainable translational process. Case studies are effective communication vehicles to demonstrate both accountability and the impacts of the public's investment in research.
Collapse
Affiliation(s)
- Sara E. Dodson
- Office of Science Policy and Planning, National Institute of Neurological Diseases and Stroke, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA
| | - Ira Kukic
- Office of Evaluation, Performance and Reporting, Division of Program Coordination, Planning, and Strategic Initiatives, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA
| | - Linda Scholl
- Office of Applied Scholarship and Education Science, Mayo Clinic College of Medicine and Science, Rochester, MN, USA
| | - Clara M. Pelfrey
- Clinical and Translational Science Collaborative, Case Western Reserve University, Cleveland, OH, USA
| | - William M. Trochim
- Clinical and Translational Science Center, Weill Cornell Medicine, Cornell University, New York, NY, USA
| |
Collapse
|
64
|
Getting the Word Out: New Approaches for Disseminating Public Health Science. JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE 2019; 24:102-111. [PMID: 28885319 PMCID: PMC5794246 DOI: 10.1097/phh.0000000000000673] [Citation(s) in RCA: 218] [Impact Index Per Article: 36.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
The gap between discovery of public health knowledge and application in practice settings and policy development is due in part to ineffective dissemination. This article describes (1) lessons related to dissemination from related disciplines (eg, communication, agriculture, social marketing, political science), (2) current practices among researchers, (3) key audience characteristics, (4) available tools for dissemination, and (5) measures of impact. Dissemination efforts need to take into account the message, source, audience, and channel. Practitioners and policy makers can be more effectively reached via news media, social media, issue or policy briefs, one-on-one meetings, and workshops and seminars. Numerous “upstream” and “midstream” indicators of impact include changes in public perception or awareness, greater use of evidence-based interventions, and changes in policy. By employing ideas outlined in this article, scientific discoveries are more likely to be applied in public health agencies and policy-making bodies.
Collapse
|
65
|
Tyler Nix A, Smith JE. Research Impact Core: A Research Impact Initiative at the University of Michigan. Med Ref Serv Q 2019; 38:260-270. [PMID: 31379282 DOI: 10.1080/02763869.2019.1623618] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
Informationists at the Taubman Health Sciences Library, University of Michigan, formed a research impact consultation and education initiative in early 2017 to increase engagement with the health sciences community around the informed, responsible use of a range of citation and alternative metrics and associated tools. So far, the Research Impact Core has primarily entailed developing training content and cultivating partnerships related to publication metrics and associated best practices. This article reports on progress from the first two years of the Research Impact Core, including a snapshot of information session registrants, and a broader discussion of collaborative partnerships around research impact in the health sciences and library system.
Collapse
Affiliation(s)
- A Tyler Nix
- a Taubman Health Sciences Library, University of Michigan , Ann Arbor , Michigan , USA
| | - Judith E Smith
- a Taubman Health Sciences Library, University of Michigan , Ann Arbor , Michigan , USA
| |
Collapse
|
66
|
Vega-Arce M, Núñez-Ulloa G, Sepúlveda-Ramírez I, Salas G, Torres Fernandez I, Pinto-Cortez C. Trends in child sexual abuse research in Latin America and the Caribbean. ELECTRONIC JOURNAL OF GENERAL MEDICINE 2019. [DOI: 10.29333/ejgm/110615] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
67
|
Goldsmith JD, Fitzgibbons PL, Fatheree LA, Astles JR, Nowak JA, Souers RJ, Volmar KE, Nakhleh RE. Evaluating the Adoption of Laboratory Practice Guidelines. Arch Pathol Lab Med 2019; 144:83-89. [DOI: 10.5858/arpa.2018-0276-cp] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
Context.—
To date, the College of American Pathologists (CAP) has developed 17 laboratory practice guidelines (LPGs) including updates. In 2013, the CAP was awarded a 5-year cooperative agreement grant from the United States Centers for Disease Control and Prevention to increase the effectiveness of LPGs.
Objective.—
To assess the awareness and adoption of 2 CAP LPGs: immunohistochemical (IHC) assay validation and initial workup of acute leukemia.
Design.—
Baseline surveys for each LPG were conducted in 2010 and 2015, respectively. To measure the adoption of guideline recommendations and inform future updates, a follow-up study consisting of surveys, telephone interviews, and focus group sessions was conducted in laboratories that indicated they perform IHC testing. A follow-up study for the acute leukemia LPG is planned.
Results.—
For the IHC Validation LPG, a total of 1624 survey responses, 40 telephone interviews, and discussions with 5 focus group participants were analyzed. The response rate for the aforementioned 3 modalities was 46%, 13%, and 3%, respectively. All modalities indicated most respondents were aware of the LPG and had adopted most or all of its recommendations. Respondents expressed needs for continued communication, increased specificity, and more prescriptive recommendations when the guideline is updated.
Conclusions.—
While data-driven development of evidence-based LPGs requires significant resources, active data collection to identify gaps and assess adoption contributes to improved laboratory testing practices in support of patient care. The CAP identified sustainable modalities to track metrics and developed multiple tools that should improve guideline development, adoption, and implementation. Of these modalities, written or electronic surveys were the most logistically feasible and had the highest response rate.
Collapse
Affiliation(s)
- Jeffrey D. Goldsmith
- From the Department of Pathology, Children's Hospital Boston, Boston, Massachusetts (Dr Goldsmith); the Department of Pathology, St. Jude Medical Center, Fullerton, California (Dr Fitzgibbons); Pathology and Laboratory Quality Center for Evidence-Based Guidelines (Ms Fatheree) and Statistics/Biostatistics (Ms Souers), College of American Pathologists, Northfield, Illinois; Division of Laboratory
| | - Patrick L. Fitzgibbons
- From the Department of Pathology, Children's Hospital Boston, Boston, Massachusetts (Dr Goldsmith); the Department of Pathology, St. Jude Medical Center, Fullerton, California (Dr Fitzgibbons); Pathology and Laboratory Quality Center for Evidence-Based Guidelines (Ms Fatheree) and Statistics/Biostatistics (Ms Souers), College of American Pathologists, Northfield, Illinois; Division of Laboratory
| | - Lisa A. Fatheree
- From the Department of Pathology, Children's Hospital Boston, Boston, Massachusetts (Dr Goldsmith); the Department of Pathology, St. Jude Medical Center, Fullerton, California (Dr Fitzgibbons); Pathology and Laboratory Quality Center for Evidence-Based Guidelines (Ms Fatheree) and Statistics/Biostatistics (Ms Souers), College of American Pathologists, Northfield, Illinois; Division of Laboratory
| | - J. Rex Astles
- From the Department of Pathology, Children's Hospital Boston, Boston, Massachusetts (Dr Goldsmith); the Department of Pathology, St. Jude Medical Center, Fullerton, California (Dr Fitzgibbons); Pathology and Laboratory Quality Center for Evidence-Based Guidelines (Ms Fatheree) and Statistics/Biostatistics (Ms Souers), College of American Pathologists, Northfield, Illinois; Division of Laboratory
| | - Jan A. Nowak
- From the Department of Pathology, Children's Hospital Boston, Boston, Massachusetts (Dr Goldsmith); the Department of Pathology, St. Jude Medical Center, Fullerton, California (Dr Fitzgibbons); Pathology and Laboratory Quality Center for Evidence-Based Guidelines (Ms Fatheree) and Statistics/Biostatistics (Ms Souers), College of American Pathologists, Northfield, Illinois; Division of Laboratory
| | - Rhona J. Souers
- From the Department of Pathology, Children's Hospital Boston, Boston, Massachusetts (Dr Goldsmith); the Department of Pathology, St. Jude Medical Center, Fullerton, California (Dr Fitzgibbons); Pathology and Laboratory Quality Center for Evidence-Based Guidelines (Ms Fatheree) and Statistics/Biostatistics (Ms Souers), College of American Pathologists, Northfield, Illinois; Division of Laboratory
| | - Keith E. Volmar
- From the Department of Pathology, Children's Hospital Boston, Boston, Massachusetts (Dr Goldsmith); the Department of Pathology, St. Jude Medical Center, Fullerton, California (Dr Fitzgibbons); Pathology and Laboratory Quality Center for Evidence-Based Guidelines (Ms Fatheree) and Statistics/Biostatistics (Ms Souers), College of American Pathologists, Northfield, Illinois; Division of Laboratory
| | - Raouf E. Nakhleh
- From the Department of Pathology, Children's Hospital Boston, Boston, Massachusetts (Dr Goldsmith); the Department of Pathology, St. Jude Medical Center, Fullerton, California (Dr Fitzgibbons); Pathology and Laboratory Quality Center for Evidence-Based Guidelines (Ms Fatheree) and Statistics/Biostatistics (Ms Souers), College of American Pathologists, Northfield, Illinois; Division of Laboratory
| |
Collapse
|
68
|
Freedland KE. The Behavioral Medicine Research Council: Its origins, mission, and methods. Health Psychol 2019; 38:277-289. [PMID: 30896214 DOI: 10.1037/hea0000731] [Citation(s) in RCA: 62] [Impact Index Per Article: 10.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
The Behavioral Medicine Research Council (BMRC) is a new, autonomous joint committee of 4 of the leading behavioral medicine research organizations, including the Academy of Behavioral Medicine Research, the American Psychosomatic Society, the Society for Health Psychology, and the Society of Behavioral Medicine. The BMRC's work has important implications for the science and practice of behavioral medicine. The distinguished senior scientists who comprise this new committee will identify a series of strategic research goals for behavioral medicine and promote systematic, interdisciplinary efforts to achieve them. This special report discusses the developments that led to the formation of the BMRC, describes the BMRC's mission, and explains the methods that its members will use. (PsycINFO Database Record (c) 2019 APA, all rights reserved).
Collapse
|
69
|
Taylor N, Best S, Martyn M, Long JC, North KN, Braithwaite J, Gaff C. A transformative translational change programme to introduce genomics into healthcare: a complexity and implementation science study protocol. BMJ Open 2019; 9:e024681. [PMID: 30842113 PMCID: PMC6429849 DOI: 10.1136/bmjopen-2018-024681] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/13/2018] [Revised: 10/21/2018] [Accepted: 11/08/2018] [Indexed: 11/25/2022] Open
Abstract
INTRODUCTION Translating scientific advances in genomic medicine into evidence-based clinical practice is challenging. Studying the natural translation of genomics into 'early-adopting' health system sectors is essential. We will (a) examine 29 health systems (Australian and Melbourne Genomics Health Alliance flagships) integrating genomics into practice and (b) combine this learning to co-design and test an evidence-based generalisable toolkit for translating genomics into healthcare. METHODS AND ANALYSIS Twenty-nine flagships integrating genomics into clinical settings are studied as complex adaptive systems to understand emergent and self-organising behaviours among inter-related actors and processes. The Effectiveness-Implementation Hybrid approach is applied to gather information on the delivery and potential for real-world implementation. Stages '1' and '2a' (representing hybrid model 1) are the focus of this protocol. The Translation Science to Population Impact (TSci Impact) framework is used to study policy decisions and service provision, and the Theoretical Domains Framework (TDF) is used to understand individual level behavioural change; both frameworks are applied across stages 1 and 2a. Stage 1 synthesises interview data from 32 participants involved in developing the genomics clinical practice systems and approaches across five 'demonstration-phase' (early adopter) flagships. In stage 2a, stakeholders are providing quantitative and qualitative data on process mapping, clinical audits, uptake and sustainability (TSci Impact), and psychosocial and environmental determinants of change (TDF). Findings will be synthesised before codesigning an intervention toolkit to facilitate implementation of genomic testing. Study methods to simultaneously test the comparative effectiveness of genomic testing and the implementation toolkit (stage 2b), and the refined implementation toolkit while simply observing the genomics intervention (stage 3) are summarised. ETHICS AND DISSEMINATION Ethical approval has been granted. The results will be disseminated in academic forums and used to refine interventions to translate genomics evidence into healthcare. Non-traditional academic dissemination methods (eg, change in guidelines or government policy) will also be employed.
Collapse
Affiliation(s)
- Natalie Taylor
- Cancer Council New South Wales, Woolloomooloo, New South Wales, Australia
- Centre for Healthcare Resilience and Implementation Science, Australian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia
- Faculty of Health Sciences, University of Sydney, Sydney, New South Wales, Australia
| | - Stephanie Best
- Centre for Healthcare Resilience and Implementation Science, Australian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia
- Australian Genomics, Murdoch Children’s Research Institute, Parkville, Victoria, Australia
| | - Melissa Martyn
- Melbourne Genomics Health Alliance, Walter and Eliza Hall Institute, Melbourne, Victoria, Australia
- Murdoch Children’s Research Institute, Royal Children’s Hospital, Parkville, Victoria, Australia
- Department of Paediatrics and Medicine, University of Melbourne, Melbourne, UK
| | - Janet C Long
- Centre for Healthcare Resilience and Implementation Science, Australian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia
| | - Kathryn N North
- Australian Genomics, Murdoch Children’s Research Institute, Parkville, Victoria, Australia
- Murdoch Children’s Research Institute, Royal Children’s Hospital, Parkville, Victoria, Australia
| | - Jeffrey Braithwaite
- Centre for Healthcare Resilience and Implementation Science, Australian Institute of Health Innovation, Macquarie University, Sydney, New South Wales, Australia
- Australian Genomics, Murdoch Children’s Research Institute, Parkville, Victoria, Australia
| | - Clara Gaff
- Melbourne Genomics Health Alliance, Walter and Eliza Hall Institute, Melbourne, Victoria, Australia
- Department of Paediatrics and Medicine, University of Melbourne, Melbourne, UK
| |
Collapse
|
70
|
Battaglia TA, Pamphile J, Bak S, Spencer N, Gunn C. Connecting Community to Research: A Training Program to Increase Community Engagement in Research. Prog Community Health Partnersh 2019; 13:209-217. [PMID: 31178456 PMCID: PMC6667830 DOI: 10.1353/cpr.2019.0021] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
BACKGROUND The Boston University Clinical & Translational Science Institute (BU CTSI) identified a local need to increase the capacity of members of a diverse inner-city community with no prior knowledge of research to partner with researchers along the research continuum. OBJECTIVES To design, implement, and evaluate an introductory- level capacity-building training using community pedagogy and providing information about current research and opportunities to partner with local researchers. METHODS Guided by two advisory boards of community-engaged professionals and patients, the community engagement team of the BU CTSI designed, implemented, and evaluated the Connecting Community to Research (CCR) training program. We targeted existing community groups in Boston interested in partnering with an academic institution to advance the health of their community. Interactive trainings focused on principles of community-engaged research (CEnR), and how individual experiences might influence research. Each session offered real-time opportunities for participants to engage with local researchers on existing research such as joining a local research advisory group or institutional review board. Self-administered surveys captured participant experiences. CONCLUSIONS Over 1 year, we trained 100 community members and almost all participants felt that the objectives of the training program were met and the information was relevant. More than 50% of the participants took advantage of partnership opportunities with local researchers. A toolkit was designed and disseminated to support others to replicate the program. We demonstrated that an interactive training curriculum designed with a community-engaged pedagogy and supported by opportunities for engagement has the ability to successfully partner community members with academic researchers.
Collapse
|
71
|
Gallo SA, Glisson SR. External Tests of Peer Review Validity Via Impact Measures. Front Res Metr Anal 2018. [DOI: 10.3389/frma.2018.00022] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|